345
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

Detection of adulteration of anti-hypertension dietary supplements and traditional Chinese medicines with synthetic drugs using LC/MS

, , , , , , & show all
Pages 893-902 | Received 18 Jul 2009, Accepted 18 Oct 2009, Published online: 08 Jun 2010
 

Abstract

A sensitive and specific liquid chromatography-electrospray ionization mass spectrometry (LC/ESI-MS) method was developed for the analysis of 18 drugs used for the treatment of anti-hypertension, including diuretics, calcium antagonists, and angiogenesis-converting enzyme inhibitors (ACEI) as adulterants in dietary supplements and traditional Chinese medicines. Separation was accomplished on a Xtimate™ C18 reversed-phase column using a mixture of methanol, acetonitrile and 20 mM ammonium formate buffer (pH 3.2) as mobile phase. The method demonstrated linearity from 0.03 to 21.52 mg kg−1. Limits of detection ranged from 6.5 to 86.0 µg kg−1. The recoveries of spiked samples ranged from 71% to 109%. The procedure was successfully applied in routine inspection analysis.

Acknowledgements

This work was financially supported by the National ‘973’ project (Grant Number 2006CB504701), the National Natural Science Foundation of China (Grant Numbers 20875028, 20080542003, and 2008[890]), and the Science Research Foundation of Hunan province (Grant Numbers 2007FJ1005 and 2008FJ3063).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.